logo
SLB Capturi and Aker Solutions Win Contract To Deliver Carbon Capture Solution for Hafslund Celsio

SLB Capturi and Aker Solutions Win Contract To Deliver Carbon Capture Solution for Hafslund Celsio

SLB (NYSE: SLB) today announced that SLB Capturi, in collaboration with Aker Solutions, has been awarded an engineering, procurement, construction, installation and commissioning (EPCIC) contract from Hafslund Celsio AS to deliver a carbon capture solution at its waste-to-energy facility in Klemetsrud, Oslo. Hafslund Celsio is Norway's largest district heating supplier and the owner and operator of Norway's largest waste-to-energy plant. Hafslund Celsio's carbon capture project is part of Longship, the Norwegian Government's full value-chain carbon capture and storage (CCS) project.
The contract award includes delivery of a carbon capture plant, liquefaction system, temporary storage, and a loading facility at the waste incineration site. It also includes an intermediate CO2 storage and ship loading system at Oslo harbor, from where the CO2 will be transported to the Northern Lights permanent storage facility on the Norwegian continental shelf. When operational, the carbon capture plant is expected to capture 350,000 metric tons of CO2 annually.
The EPCIC award follows a cost reduction phase for Hafslund Celsio's project, which identified opportunities for efficiencies, including layout optimization. The project will now be delivered based on SLB Capturi's modularized Just Catch™ 400 unit. The space-efficient Just Catch design has been fundamental to enabling a viable, cost-effective solution by reducing onsite footprint, installation, and outfitting work.
'Standardization and modularization play a key role in shifting the economics of carbon capture projects,' said Egil Fagerland, chief executive officer, SLB Capturi. 'We are extremely proud of our collaboration with Hafslund Celsio and Aker Solutions to align our Just Catch plant design with the techno-economic requirements of this project to help make it a reality. We look forward to delivering this flagship project as a successful blueprint for industrial decarbonization projects in Norway and across the globe.'
Hafslund Celsio's project is the second carbon capture plant in Longship, where SLB Capturi is already delivering the carbon capture plant at Heidelberg Materials' cement facility in Brevik in collaboration with Aker Solutions.
'Today marks a significant milestone for Aker Solutions and the CCS industry in Norway. We are proud to be part of this key project and look forward to contributing with our effective project execution, based on three decades of experience in the CCS market. This project is a testament to important public and private collaboration to build an industrial value chain for carbon capture and storage. The project will also significantly contribute to reducing emissions and will create value for both industry and society,' said Kjetel Digre, CEO for Aker Solutions.
'We are pleased to have Aker Solutions and SLB Capturi collaborating with us on this significant industrial project,' stated Martin S. Lundby, chief executive officer at Hafslund Celsio. 'Working with reputable partners who possess extensive experience in carbon capture and storage from the Longship project provides us with security and strength. Our partners bring valuable expertise from large industrial developments both in Norway and internationally. Together, we will construct a carbon capture solution that is expected to be operational by third quarter 2029.'
About SLB SLB (NYSE: SLB) is a global technology company that drives energy innovation for a balanced planet. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at slb.com.
About SLB Capturi SLB Capturi is a joint venture between SLB and Aker Carbon Capture, dedicated to carbon removal and reduction solutions. The company's proven modular technologies enable industries to deploy capture technology at speed and scale, meeting the requirements of tomorrow and the opportunities of today. The company is currently delivering seven carbon capture plants to bioenergy, waste to energy, and cement facilities. Find out more at capturi.slb.com
About Aker Solutions Aker Solutions delivers integrated solutions, products and services to the global energy industry. The company enables low-carbon oil and gas production and develops renewable solutions to meet future energy needs. By combining innovative digital solutions and predictable project execution Aker Solutions aims to accelerate the transition to sustainable energy production. Find out more at akersolutions.com
About Hafslund Celsio Hafslund Celsio AS is the largest producer and supplier of district heating in Norway and supplied 25 % of the district heating generated in Norway in 2023. In 2024, the company produced 1.9 TWh of district heating. Hafslund Celsio's waste-to-energy plant at Klemetsrud, Oslo, is Norway's largest with a capacity to end-treat 350,000 tonnes of waste per year. The company is also expanding its activities to district cooling. The company employs approximately 232 people. Hafslund Celsio is owned by a Norwegian investor consortium comprising Hafslund (60%), Infranode (20%) and HitecVision (20%).
Media Josh Byerly – SVP of Communications Moira Duff – Director of External Communications SLB Tel: +1 (713) 375-3407 Email: [email protected]
Investors James R. McDonald – SVP of Investor Relations & Industry Affairs Joy V. Domingo – Director of Investor Relations SLB Tel: +1 (713) 375-3535 Email: [email protected]
Cautionary Statement Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the U.S. federal securities laws — that is, statements about the future, not about past events. Such statements often contain words such as 'expect,' 'may,' 'can,' 'estimate,' 'intend,' 'anticipate,' 'will,' 'potential,' 'projected' and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as forecasts or expectations regarding the deployment of, or anticipated benefits of, SLB's new technologies and partnerships; statements about goals, plans and projections with respect to sustainability and environmental matters; forecasts or expectations regarding energy transition and global climate change; and improvements in operating procedures and technology. These statements are subject to risks and uncertainties, including, but not limited to, the inability to achieve net-negative carbon emissions goals; the inability to recognize intended benefits of SLB's strategies, initiatives or partnerships; legislative and regulatory initiatives addressing environmental concerns, including initiatives addressing the impact of global climate change; the timing or receipt of regulatory approvals and permits; and other risks and uncertainties detailed in SLB's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes), or should underlying assumptions prove incorrect, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, and SLB disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.
View original content here.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

Yahoo

time14 minutes ago

  • Yahoo

NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO

NEW YORK, July 31, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on July 31st Equities are catching a bid early Thursday after decent earnings reports from tech giants Microsoft and Meta. Apple and Amazon report their earnings after today's market close. Figma, which provides browser-based design software, raised $1.2 billion after pricing nearly 37 million shares at $33 each. The price was above an upwardly revised range and valued Figma at more than $19 billion. Shoulder Innovations priced five million shares at $15 each in its IPO. The company is a commercial stage shoulder surgery focused Medtech founded in 2009. Opening BellFigma (NYSE: FIG) celebrates its initial public offering Closing BellShoulder Innovations (NYSE: SI) celebrates its initial public offering Click here to download the NYSE TV App View original content to download multimedia: SOURCE New York Stock Exchange Sign in to access your portfolio

Mastercard rises 2% premarket on Q2 earnings, revenue beat
Mastercard rises 2% premarket on Q2 earnings, revenue beat

Yahoo

time14 minutes ago

  • Yahoo

Mastercard rises 2% premarket on Q2 earnings, revenue beat

-- Mastercard shares rose 2% in premarket trading after the payments company posted better-than-expected second-quarter earnings and revenue on the back of robust consumer spending. Adjusted earnings per share came in at $4.15, topping the consensus estimate of $4.03. Revenue for the quarter reached $8.13 billion, ahead of expectations of $7.93 billion. The company said net revenue grew 17% year-over-year, or 16% on a currency-neutral basis, driven by continued growth in consumer spending and cross-border volumes. CEO Michael Miebach highlighted recent business wins, including the extension of its exclusive partnership with American Airlines (NASDAQ:AAL). 'We're well positioned for the opportunities ahead and continue to drive new innovation like the Mastercard (NYSE:MA) Collection and Mastercard Agent Pay,' Miebach said. Related articles Mastercard rises 2% premarket on Q2 earnings, revenue beat These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Should You Invest in Penumbra (PEN)?
Should You Invest in Penumbra (PEN)?

Yahoo

time14 minutes ago

  • Yahoo

Should You Invest in Penumbra (PEN)?

Baron Funds, an investment management company, released its 'Baron Health Care Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care Index (benchmark) and a 10.99% gain for the Russell 3000 Index (the Index). In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Penumbra, Inc. (NYSE:PEN). Headquartered in Alameda, California, Penumbra, Inc. (NYSE:PEN) designs and manufactures medical devices. The one-month return of Penumbra, Inc. (NYSE:PEN) was 1.25%, and its shares gained 48.44% of their value over the last 52 weeks. On July 30, 2025, Penumbra, Inc. (NYSE:PEN) stock closed at $254.21 per share, with a market capitalization of $9.914 billion. Baron Health Care Fund stated the following regarding Penumbra, Inc. (NYSE:PEN) in its second quarter 2025 investor letter: "We added to our position in Penumbra, Inc. (NYSE:PEN), a medical device company that manufactures mechanical thrombectomy devices to remove clots. We think Penumbra's products are differentiated because of their computer assisted vacuum thrombectomy (CAVT) technology. CAVT utilizes algorithms to modulate the aspiration power depending on if a clot is detected, and to control a separate valve that injects saline to reduce friction between the clot and catheter. This maximizes clot removal while decreasing risk of blood loss. For U.S. thrombectomy, we see a market opportunity for over 1 million procedures a year across stroke and peripheral vascular, with a total addressable market (TAM) north of $8 billion. Of this TAM, Penumbra is only high single digits percentage penetrated in 2024. We are looking forward to this mechanism rolling out in the stroke setting (the Thunderbolt product which is in development). In addition, the company is seeing strong momentum in the venous setting already with their Flash product. We think this momentum could accelerate if the Storm-PE trial, which completed enrollment during the quarter, demonstrates superiority of Penumbra's CAVT plus anticoagulation versus anticoagulation alone (the current standard of care) in intermediate-high risk pulmonary embolism patients. The trial could change the treatment paradigm for pulmonary embolism." A close-up view of a technician wearing protective gloves while installing a mechanical thrombectomy system. Penumbra, Inc. (NYSE:PEN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 47 hedge fund portfolios held Penumbra, Inc. (NYSE:PEN) at the end of the first quarter, which was 35 in the previous quarter. In the second quarter of 2025, Penumbra, Inc. (NYSE:PEN) reported revenue of $339.5 million, marking year-over-year increase of 13.4% on a reported basis and 12.7% on a constant currency basis. While we acknowledge the potential of Penumbra, Inc. (NYSE:PEN) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Penumbra, Inc. (NYSE:PEN) and shared the list of best mid-cap healthcare stocks to buy according to hedge funds. Baron Health Care Fund initiated a position in Penumbra, Inc. (NYSE:PEN) during Q1 2025. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store